Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures

Clinical trial NCT01527513 · COMPLETED

Trial details

NCT number: NCT01527513
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Partial Epilepsy

Start date: 2010-08-01
Primary completion: 2012-03-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.